Workshop on how to implement the recently released EMA guideline on ‘First-in-Human’ trials?

Paris, France

Organised by Club Phase 1

23 November 2017, 13:30 pm to 16:30 pm

Maison de la Chimie, 28, rue Saint Dominique, 75007 PARIS

 

 

A practical and interactive conference with broad early development stakeholders.

Speakers

Pr. Dominique Deplanque, MD, PhD

Professor of Medical Pharmacology
University Lille 2 – Inserm – CHU of Lille, France
National coordinator of the French Clinical Investigation Centers (CIC)
Medical coordinator of CIC1403 – Lille
INSERM laboratory U1171 (Degenerative and vascular cognitive disorders)

Dr. Christophe Massard, MD, PhD

Medical Oncologist
Institut Gustave Roussy – University Paris Sud, France
Head of Gustave Roussy Drug Development Department (DITEP)

Pr. Marc Pallardy, PharmD, PhD

Professor in toxicology
University Paris Sud, France
Dean Faculty of Pharmacy
Team Leader of the INSERM laboratory UMR 996 “Cytokines, chemokines and immunopathology”

Dr. Yves Donazzolo, MD, MSc

Clinical Pharmacologist
Optimed-Eurofins, Grenoble, France
CEO
Early clinical development trials investigator

Dr. Dominique Masset, PharmD, PhD

Agence Nationale de Sécurité du Médicament (ANSM), Saint-Denis, France
Head of Pharmaceutical Quality, Viral Safety Toxicology and Non-Clinical Evaluation

Dr. Marc Martin, PhD

Agence Nationale de Sécurité du Médicament (ANSM), Saint-Denis, France
Deputy-Head Evaluation Division

Read more: Download flyer here

Register before 15 November, as places are limited.